Amanote Research
Register
Sign In
Dual EGFR and mTOR Targeting in Squamous Cell Carcinoma Models, and Development of Early Markers of Efficacy
British Journal of Cancer
- United Kingdom
doi 10.1038/sj.bjc.6603656
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
March 1, 2007
Authors
A Jimeno
P Kulesza
J Wheelhouse
A Chan
X Zhang
E Kincaid
R Chen
D P Clark
A Forastiere
M Hidalgo
Publisher
Springer Science and Business Media LLC
Related search
PET of EGFR Antibody Distribution in Head and Neck Squamous Cell Carcinoma Models
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Dual Inhibition of EGFR and mTOR Pathways in Small Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
Immunoexpression of Cell Proliferation Markers in Oral Squamous Cell Carcinoma
International journal of odontostomatology
Gephyrin Suppresses Lung Squamous Cell Carcinoma Development by Reducing mTOR Pathway Activation
Cancer Management and Research
Oncology
EGFR Modulates Complement Activation in Head and Neck Squamous Cell Carcinoma
BMC Cancer
Cancer Research
Oncology
Genetics
Lovastatin Inhibits EGFR Dimerization and AKT Activation in Squamous Cell Carcinoma Cells: Potential Regulation by Targeting Rho Proteins
Oncogene
Cancer Research
Genetics
Molecular Biology
Co-Targeting EGFR and IKKβ/NF-κB Signalling Pathways in Head and Neck Squamous Cell Carcinoma: A Potential Novel Therapy for Head and Neck Squamous Cell Cancer
British Journal of Cancer
Cancer Research
Oncology
Cancer Stem Cell Markers in Patterning Differentiation and in Prognosis of Oral Squamous Cell Carcinoma
Tumor Biology
Medicine
Cancer Research
Role of Inflammatory Markers in Prognosis of Oral Squamous Cell Carcinoma
Asian Pacific Journal of Cancer Prevention
